Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion type Assertion NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_head.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion description "[We therefore next analyzed compound heterozygote effects in 77 subjects with either hypocretin deficiency or cataplexy and one copy of DRB1*1501-DQA1*0102-DQB1*0602, a sample constructed to maximize etiologic homogeneity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_provenance.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion evidence source_evidence_literature NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_provenance.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion SIO_000772 17207713 NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_provenance.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion wasDerivedFrom befree-20140225 NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_provenance.
- NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_assertion wasGeneratedBy ECO_0000203 NP792729.RAmktD1UbgcO9c_9fPFreJOhqedsZYQysiYB8flBV11jA130_provenance.